Result of the treatment of a recurrent giant cell tumour in the middle phalanx by combined bone grafting and restoration of the PIP joint: a case report.

• References

• 1 van der Heijden L, Dijkstra PD, Blay JY. et al. Giant cell tumour of bone in the denosumab era. Eur J Cancer 2017; 77: 75-83
• 2 Harness NG, Mankin HJ. Giant-cell tumor of the distal forearm. J Hand Surg 2004; 29 A: 188-193
• 3 Adulkasem N, Pruksakorn D. Giant cell tumour of the middle phalanx of the middle finger. BMJ Case Rep 2019; 25: 12 pii: e229076. doi: 10.1136/bcr-2018–229076
• 4 Campanacci M, Baldini N, Boriani S. et al. Giant-cell tumor of bone. J Bone Joint Surg Am 1987; 69: 106-114
• 5 Thomas D, Henshaw R, Skubitz K. et al. Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study. Lancet Oncol 2010; 11: 275-280
• 6 Lau CP, Huang L, Wong KC. et al. Comparison of the anti-tumor effects of denosumab and zoledronic acid on the neoplastic stromal cells of giant cell tumor of bone. Connect Tissue Res 2013; 54: 439-449
• 7 Spiro AS, Pogoda P, Amling M. et al. Giant cell tumour of bone: reconstruction of the index metacarpophalangeal joint with an osteochondral graft from the lateral femoral condyle. J Plast Reconstr Aesthet Surg 2013; 66: 729-732
• 8 Lewallen LW, Wagner ER, Moran SL. Giant cell tumor of the metacarpal: Case report. Hand (NY) 2017; 12: 113-117
• 9 Kanaya K, Wada T, Kitajima K. et al. Vascularized metatarsophalangeal joint transfer for giant cell tumor of the proximal phalanx of the hand. Plast Reconstr Surg 2008; 121: 354-355